On November 14, 2017 A-View® obtained approval from the Australian Therapeutic Goods Administration (TGA). The approval was realized in collaboration with Advanced Biomedical Pty Ltd, the exclusive distribution partner for A-View® in Australia. Market launch will during the ATCSA in Melbourn on November 16-19, 2017.
Stroke2prevent & A-View
Stroke2prevent B.V. develops, manufactures and distributes medical devices. Our product A-View® is used to resolve the so called ‘blind-spot’ caused by interposition of the trachea in Transoesophageal Echocardiography (TEE). A-View® provides images of the images of the entire thoracic aortic arch allowing detection of atherosclerosis, diagnosing aortic diseases and to permits monitoring of vascular flow. The additional information obtained by A-View® supports physicians to ensure the best patient outcomes.